Pressure BioSciences Inc (PBIO)
0.0065
0.00 (0.00%)
USD |
OTCM |
Nov 12, 16:00
Pressure BioSciences Enterprise Value: 26.75M for Nov. 11, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 11, 2024 | 26.75M |
| November 08, 2024 | 26.73M |
| November 07, 2024 | 26.77M |
| November 06, 2024 | 26.77M |
| November 05, 2024 | 26.77M |
| November 04, 2024 | 26.72M |
| November 01, 2024 | 26.66M |
| October 31, 2024 | 26.60M |
| October 30, 2024 | 26.60M |
| October 29, 2024 | 27.07M |
| October 28, 2024 | 27.07M |
| October 25, 2024 | 27.07M |
| October 24, 2024 | 27.07M |
| October 23, 2024 | 27.07M |
| October 22, 2024 | 27.07M |
| October 21, 2024 | 27.07M |
| October 18, 2024 | 27.07M |
| October 17, 2024 | 27.07M |
| October 16, 2024 | 27.07M |
| October 15, 2024 | 27.07M |
| October 14, 2024 | 27.07M |
| October 11, 2024 | 27.07M |
| October 10, 2024 | 27.03M |
| October 09, 2024 | 27.03M |
| October 08, 2024 | 27.03M |
| Date | Value |
|---|---|
| October 07, 2024 | 27.03M |
| October 04, 2024 | 27.03M |
| October 03, 2024 | 27.03M |
| October 02, 2024 | 27.50M |
| October 01, 2024 | 27.50M |
| September 30, 2024 | 27.36M |
| September 27, 2024 | 27.36M |
| September 26, 2024 | 27.56M |
| September 25, 2024 | 27.56M |
| September 24, 2024 | 27.56M |
| September 23, 2024 | 27.56M |
| September 20, 2024 | 27.56M |
| September 19, 2024 | 27.93M |
| September 18, 2024 | 27.54M |
| September 17, 2024 | 27.54M |
| September 16, 2024 | 27.54M |
| September 13, 2024 | 27.54M |
| September 12, 2024 | 27.54M |
| September 11, 2024 | 27.54M |
| September 10, 2024 | 27.46M |
| September 09, 2024 | 27.46M |
| September 06, 2024 | 27.46M |
| September 05, 2024 | 27.46M |
| September 04, 2024 | 27.46M |
| September 03, 2024 | 27.44M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
8.274M
Minimum
Dec 18 2019
49.53M
Maximum
Jan 26 2023
27.10M
Average
29.60M
Median
Sep 23 2022
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 428.29M |
| Retractable Technologies Inc | -18.98M |
| InfuSystems Holdings Inc | 230.30M |
| Xtant Medical Holdings Inc | 102.88M |
| Catheter Precision Inc | 1.924M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.074M |
| Revenue (Quarterly) | 0.3493M |
| Total Expenses (Quarterly) | 1.834M |
| EPS Diluted (Quarterly) | -0.22 |
| Gross Profit Margin (Quarterly) | 33.20% |
| Profit Margin (Quarterly) | -2.31K% |
| Earnings Yield | -21.23K% |
| Normalized Earnings Yield | -18567.83 |